These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25428558)

  • 21. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia.
    Titaley CR; Damayanti R; Soeharno N; Mu'asyaroh A; Bradley M; Lynam T; Krentel A
    Parasit Vectors; 2018 May; 11(1):315. PubMed ID: 29801511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
    Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
    Ojha CR; Joshi B; Kc KP; Dumre SP; Yogi KK; Bhatta B; Adhikari T; Crowley K; Marasini BR
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005788. PubMed ID: 28723904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.
    Njenga SM; Kanyi HM; Mutungi FM; Okoyo C; Matendechero HS; Pullan RL; Halliday KE; Brooker SJ; Wamae CN; Onsongo JK; Won KY
    Parasit Vectors; 2017 Feb; 10(1):99. PubMed ID: 28228160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
    Cantey PT; Rout J; Rao G; Williamson J; Fox LM
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e728. PubMed ID: 20628595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphatic filariasis baseline survey in two sentinel sites of Ogun state, Nigeria.
    Okorie PN; Davies E; Ogunmola OO; Ojurongbe O; Saka Y; Okoeguale B; Braide EI
    Pan Afr Med J; 2015; 20():397. PubMed ID: 26185587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.
    de Souza DK; Ansumana R; Sessay S; Conteh A; Koudou B; Rebollo MP; Koroma J; Boakye DA; Bockarie MJ
    Parasit Vectors; 2015 Sep; 8():488. PubMed ID: 26399968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
    Kusi C; Steinmann P; Merten S
    Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
    Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
    BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of factors related to individuals who were never treated during mass drug administration for lymphatic filariasis in Ambon City, Indonesia.
    Titaley CR; Worrell CM; Ariawan I; Taihuttu YMJ; de Lima F; Naz SF; Que BJ; Krentel A
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010900. PubMed ID: 36367853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?
    Kelly-Hope LA; Molyneux DH; Bockarie MJ
    Parasit Vectors; 2013 Feb; 6():39. PubMed ID: 23433078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of knowledge, attitudes, and perceptions (KAPs) of lymphatic filariasis, elephantiasis, and hydrocele among residents in an endemic area in Haiti.
    Eberhard ML; Walker EM; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 1996 Mar; 54(3):299-303. PubMed ID: 8600770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries.
    Huppatz C; Capuano C; Palmer K; Kelly PM; Durrheim DN
    BMC Infect Dis; 2009 Jun; 9():92. PubMed ID: 19523192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge and beliefs about elephantiasis and hydrocele of lymphatic filariasis and some socio-demographic determinants in an endemic community of Eastern India.
    Babu BV; Hazra RK; Chhotray GP; Satyanarayana K
    Public Health; 2004 Mar; 118(2):121-7. PubMed ID: 15037042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptance of Mass Drug Administration for Prophylaxis against Lymphatic Filariasis in a Tribal Endemic Area: A Descriptive Cross-sectional Study.
    Agarwal A; Maharshi V
    Indian J Public Health; 2024 Apr; 68(2):194-200. PubMed ID: 38953805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community's knowledge and perceptions about filarial elephantiasis and hydrocele in coastal Orissa, India.
    Rath K; Nayak AN; Babu BV
    Asia Pac J Public Health; 2007; 19(1):28-33. PubMed ID: 17784656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza ET; Gasarasi DB; Minzi OM
    PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
    Mehta PK; Maharjan M
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis.
    Ramaiah KD; Vijay Kumar KN; Ravi R; Das PK
    Ann Trop Med Parasitol; 2005 Apr; 99(3):243-52. PubMed ID: 15829134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.